(Q35045927)

6 August 2017

1 reference

title

Lowering anti-dsDNA antibodies--what's new? (English)

1 reference

6 August 2017

A Davidson

7

0 references

author name string

L E Schiffer

1

1 reference

6 August 2017

N Hussain

2

1 reference

6 August 2017

X Wang

3

1 reference

6 August 2017

W Huang

4

1 reference

6 August 2017

J Sinha

5

1 reference

6 August 2017

M Ramanujam

6

1 reference

6 August 2017

1 January 2002

1 reference

6 August 2017

1 reference

6 August 2017

11

1 reference

6 August 2017

885-894

1 reference

6 August 2017

12

1 reference

Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus

6 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Anti-dsdna and complement profiles as prognostic guides in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Murine lupus genetics: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Lessons from the NZM2410 model and related strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Delineating the genetic basis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

T-Cell Function and Migration — Two Sides of the Same Coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Lymphoid tissue homing chemokines are expressed in chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Nephritogenic autoantibodies in lupus: current concepts and continuing controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Anti-DNA meets NMDA in neuropsychiatric lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

B cell development pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

BAFF mediates survival of peripheral immature B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Long-lived plasma cells: a mechanism for maintaining persistent antibody production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Plasma cells for a lifetime?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Plasma cells: finding new light at the end of B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Treatment of murine lupus with CTLA4Ig

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Clinical and pharmacological experience with LJP-394.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

The potential use of peptides and vaccination to treat systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Induction of autoantibody production is limited in nonautoimmune mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

CpG-DNA derived from sera in systemic lupus erythematosus enhances ICAM-1 expression on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU311RR

10.1191/0961203302LU311RR

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference